VC
CRL icon

VarCov Co’s Charles River Laboratories CRL Stock Holding History

VarCov Co’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
+4,547
New +$810K 0.39% 89
2026
Q1 		– Sell
-1,774
Closed -$354K – 425
2025
Q4 		$354K Buy
+1,774
New +$322K 0.14% 251

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

VarCov Co's CRL Position: Q2 2026 in Review

VarCov Co opened a new position in Charles River Laboratories (CRL) in Q2 2026: 4,547 shares worth $1.03M. The stake represents 0.39% of the portfolio and ranks #89 among its holdings. This is a return to the name: VarCov Co previously reported a position in CRL as recently as Q4 2025.

VarCov Co first reported a position in CRL in Q4 2025 and has held it in 2 quarters since. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • VarCov Co held 4,547 shares of Charles River Laboratories worth $1.03M as of Q2 2026.
  • Charles River Laboratories was a new VarCov Co position in Q2 2026.
  • Charles River Laboratories made up 0.39% of VarCov Co's portfolio in Q2 2026, its #89 holding.
  • VarCov Co first reported a position in Charles River Laboratories in Q4 2025 and has held it in 2 quarters since.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on VarCov Co's 13F filing for Q2 2026, filed 14 Aug 2026.